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Abstract Objective To study clinical characteristics of endolymphatic sac tumor（ELST）and its diagnosis and treat⁃
ment. Methods ELST was diagnosed in 6 cases based on surgical and histological findings. These cases were re⁃
viewed for their clinical manifestations, differential diagnosis and surgical treatment techniques. Results There were
1 male and 5 females in this group, aged from 28 to 59 years（mean age=38.7 years）. The tumor was in left ear in 4
cases and in right ear in the other 2 cases. Disease courses ranged from 5 to 30 years（mean duration=12.6 years）.
Clinical presentations included sensorineural hearing loss（n=4）, otorrhea and tinnitus（n=2）, tinnitus and facial
spasm（n=1）, otorrhea with facial paralysis（n=1）, and hearing loss with tinnitus（n=2）. None of the cases was diag⁃
nosed as ELST preoperatively. Two cases were misdiagnosed as glomus jugulare tumor, 2 as chronic suppurative oti⁃
tis media, 1 as sweat gland adenoma on biopsy and 1 as temporal bone tumor. Tumors were surgically resected in all
6 cases via the mastoidectomy（n=2）or combined oto-cervical or cranio-oto-cervical approaches（n=4）. Postopera⁃
tive cerebrospinal fluid otorrhea occurred in 1 case. The tumors were confirmed on histological examination to be a
low-grade adenocarcinoma. All patients have survived at the time of this paper. Conclusion ELST is rare and com⁃
monly misdiagnosed and inadequately treated. Its prognosis is relatively favorable because of its slow growth rate.
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Introduction
Endolymphatic sac tumor（ELST） is a rare and
low-grade malignancy. However, its unique anatomical
location and relationship with neighboring important
neural and vascular structures make its diagnosis and
treatment a challenge. Surgical approaches for ELST re⁃
section can be difficult and surgical complications are
not uncommon and sometimes fatal. A thorough knowl⁃
edge of its clinical presentation and imaging features is
critical for adequate management of this condition.
This paper reports 6 cases of histologically confirmed
ELST treated at the Chinese PLA General Hospital.
Patient Data
Case 1. A 28 years old female presented with left side
chronic otorrhea, progressive hearing loss and facial
weakness of 8 years. Otoscopy revealed a dark red mass
from the left tympanic cavity（TC）and fullness in poste⁃
rior canal wall of the external auditory canal（EAC）. Au⁃
diometry showed complete hearing loss in left ear. CT
and MRI scans demonstrated a lesion of irregular signal
densities invading the petrous temporal bone and the in⁃
ternal auditory canal（IAC）with compression effects on
the temporal lobe and cerebellum. Surgical resection
was attempted via an extended temporal bone resection
through a combined cranio-oto-cervical approach. A
mass lesion was found to occupy the medial portion of
the EAC, TC and mastoid, invading the mastoid segment
of the fallopian canal and anterior wall of the sigmoid si⁃
nus. The dura was intact. Following resection of the le⁃
sion including part of the facial nerve, the defect was
obliterated with a musculofascial graft, with primary hy⁃
poglosso-facial nerve anastomosis（HFNA）. Blood loss
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was estimated at 1000 ml. Postoperative cerebrospinal
fluid（CSF）leak was successfully controlled 10 days lat⁃
er with a revision repair procedure under general anes⁃
thesia. Pathology report indicated low grade papillotubu⁃
lar adenocarcinoma, staining positive for keratin (++ )
and S-100 protein（in a small number of tumor cells）,
and negative for chromogranin A（CgA）and neurofila⁃
ment protein（NFP）.
Case 2. A 48 years old woman presented with left side
pulsating tinnitus, hearing loss of 5 years and facial
spasm of 2 months. Other symptoms included fullness,
vertigo attacks, facial numbness and bloody otorrhea.
Physical examination（PE）showed a red mass in the in⁃
feroposterior TC and left facial paresis. Audiometry
showed left total hearing loss. Imaging studies suggested
glomus jugulare tumor（GJT）. Surgical resection was at⁃
tempted via a retromastoid approach following emboliza⁃
tion of the supplying artery. The lesion invaded the TC,
mastoid, occipital bone, jugular foramen（JF）and local
dura. A temporalis myofascial graft was used to repair
dura defect following resection of the mass and involved
section of the facial nerve. Primary HFNA was per⁃
formed. Low grade papilloadenocarcinoma was reported
on histological examination.
Case 3. A 25 years old young woman presented with
right side pulsating tinnitus of 10 years and facial weak⁃
ness of 7 years. PE showed a red mass lesion in the EAC
with tuning fork tests suggesting right side sensorineural
loss. MRI scans suggested well demarcated mastoid and
jugular bulb mass lesion with rich blood supply and lo⁃
cal bone erosion. Severe bleeding occurred at biopsy
and forced abortion of a local resection attempt. Resec⁃
tion was attempted again via an oto-cervical approach.
A dark red mass lesion was found to occupy the EAC,
TC and mastoid, causing destruction of the posterior
EAC wall. Dura over the sigmoid sinus remained intact.
Pathology report confirmed a low grade adenocarcinoma
from the endolymphatic sac（ELS）, staining positive for
keratin and neuron-specific enolase（NSE）.
Case 4. This was a 38 years old woman with right side
intermittent otorrhea and hearing loss of 30 years and
dizziness shortly before presentation. Otoscopy revealed
retracted tympanic membrane. Hearing tests showed
right side total loss. CT scans demonstrated soft tissue
shadow filling the TC, attic and mastoid. Otitis media
with cholesteatoma was suspected and a tympanomas⁃
toidectomy was planned. Large amount of granulation tis⁃
sue was seen during the surgery with no cholesteatoma.
The dura was exposed and intact. Low grade adenocarci⁃
noma from the ELS was reported on pathology report.
Case 5. A 59 years old male complained of left side
tinnitus and hearing loss of 10 years and suppurative
and later bloody otorrhea of 4 years. PE revealed a red
mass in the EAC. Audiometric tests showed left side to⁃
tal hearing loss. CT and MRI scans indicated“mass le⁃
sion at the JF consistent with neurogenic or glomus tu⁃
mors”. Digital subtraction angiography（DSA） con⁃
firmed a vascular mass. Embolization using polyvinyl al⁃
cohol and gel foam was performed to reduce blood sup⁃
ply to the mass. Resection was attempted via a com⁃
bined lateral ear-neck approach. The lesion was found
to invade the TC and mastoid and easily separated from
the dura. It was shown to be an invasive papilloma from
the ELS with negative staining for CgA, synaptophysin
（Syn）, calcitonin, thyroglobulin（TG）and thyroid tran⁃
scription factor-1.
Case 6. A 34 years old female complained of left side
pulsating tinnitus and hearing loss of 6 months. A red
mass in the inferoposterior wall in the medial portion of
the EAC was seen on otoscopy. Pure tone audiometry
showed left side conductive loss. CT and MRI studies in⁃
dicated highly enhanced temporal bone mass. First re⁃
section attempt was aborted as a simple biopsy resulted
in severe bleeding. Pathology report suggested low grade
malignant neoplasm from the ELS staining positive for
cytokeratin AE3, S-100 and Ki-67 antigen, and nega⁃
tive for TG, NSE, CgA, Syn, CD31, CD34 and factor
VIII related antigen. Resection was attempted again via
a partial temporal bone resection following tumor emboli⁃
zation. Albeit difficult due to rather severe bleeding, tu⁃
mor removal was complete, including the lesion involv⁃
ing the ELS. Postoperative recovery was uneventful.
Discussion
ELST originates from the pars rugosa of the ELS. Its ter⁃
minology remains controversial. Names such as aggres⁃
sive papillary tumor of the middle ear, aggressive papil⁃
lary tumor of temporal bone and ELS and low-grade ade⁃
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Fig .1 CT scans of ELST showing irregular signal density and low signal areas（arrow heads）.
nocarcinoma of ELS have been used. Since it shares
many histological features of the ELS, the ELS has been
widely accepted as its origin［1］. Because it is often seen
in von Hippel-Lindau disease, it is also considered an
otological representation of von Hippel-Lindau disease.
von Hippel-Lindau disease is an autosomal dominant
syndrome with predisposition to neoplasms involving the
retina, central nervous system, viscera and ELS［2］. Fur⁃
ther investigation for possible neoplasms such as angio⁃
mas in the retina and brain, renal carcinoma and other
neoplasms in the pancreas, adrenal glands and epididy⁃
mis is recommended in patients diagnosed with ELST［3］.
None of these neoplasms was found in this series.
ELST is considered a low grade malignancy because
of its slow growth rate, high degree of cellular differentia⁃
tion, rare distant metastasis and relatively benign progno⁃
sis. Average disease duration in the current series was
12.6 years. It often takes years for symptoms to develop
and for the patient to seek medical care, indicting a slow
disease course and favorable prognosis. Patients who re⁃
ceived partial disease resection have been reported to
survive for 10 years or longer［1］. All 6 patients in this se⁃
ries survived during the 10 months to 8 years follow up.
Clinically, ELST often presents with typical otological
manifestations, including hearing loss, tinnitus and dizzi⁃
ness. Hearing loss is usually sensorineural in nature and
can present as sudden SNHL［4］. Hearing loss was identi⁃
fied in all cases in this series, with total loss in 4 cases.
Other typical features include symptoms simulating oti⁃
tis media（Cases 1, 4 and 5 in this series）and red col⁃
ored mass and blood-tinted discharge in the EAC. In
cases with advance lesion, functions of the facial nerve
and/or lower cranial nerves will be compromised, result⁃
ing in facial paralysis/spasm, hoarseness and tongue atro⁃
phy.
There lack studies on age and gender distributions in
ELST, although it seems to affect females more than
males. Five of the 6 cases in this series are female.
There is a wide age range for this disease（10-80 years）
［5］, and the onset age can be as young as 4 years［6］. The
average age in this group is 39.8 years.
Imaging studies in ELST typically reveal destruction
of bony structures between the IAC and sigmoid sinus,
often involving the posterior cranial fossa. Bony erosion
is sometimes limited to the mid section of the petrous
temporal bone, but can be extensive and involving the
mastoid, TC and JF. Irregular signal enhancement is
commonly seen on ELST images, often showing calcifica⁃
tion and cystic or necrotic changes（Fig 1 and 2）. DSA
images usually indicate rich blood supply, but not as
strong or homogeneous as in GJT or meningioma and
sometimes with non-vascular（cystic）areas（Fig 3）.
Histologically, ELST features papilloglandular pat⁃
terns［7］ that can be dominated by either colloidal or pap⁃
illary areas［8］. The glandular structures contain large
number of papillae and cysts covered by cuboidal or flat
epithelium and are rich in blood vessels, similar to cho⁃
roid plexus papilloma. The cysts are filled with colloidal
substance, similar to papillary carcinoma of thyroid.
Clear cells can be seen, as in clear cell carcinoma of kid⁃
ney. Because the ELS derives from the neuroectoderm,
immunohistological staining for epithelial membrane an⁃
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Fig.2 Irregular enhancement on an MRI scan. Fig.3 Rich blood supply demonstrated on DSA images with non-vascular areas (cys⁃
tic changes).
tigen（EMA） and NSE can help diagnosis ［9］, usually
positive for CK and NSE and negative for EMA, glial fi⁃
brillary acidic protein（GFAP）, TG, CgA, Syn and
S-100. None of these tests are specific for ELST, but
nonetheless helpful［7］.
Important differentials in ELST include GJT,
schwannoma, meningioma, metastatic malignancies and
middle ear carcinoma. Because of its retro- labyrinthine
origin site, early ELST is located superior, lateral and
anterior to a typical GJT which is inferior to the laby⁃
rinth. The difference is however not discernable in ad⁃
vanced cases. Enhancement is usually irregular in ELST
with possible non-vascular areas, in contrast to that in
GJT which is usually homogenous with“salt and pepper
sign”. Hearing loss in GJT is usually conductive.
Schwannoma in the JF area is rare and can also show ir⁃
regular enhancement and cystic signs on imaging, but
bone destruction is usually a result of compression not
erosion and otorrhea and SNHL are uncommon. Meningi⁃
oma in the same area can cause bony destruction and
lower cranial nerves dysfunction, usually without SNHL,
tinnitus or dizziness. Its imaging is characterized by cal⁃
cification, strong enhancement, rich blood supply and
unique meningeal“tail sign”. Cystic changes are rare in
meningioma. Acoustic neuroma and choroid plexus pap⁃
illoma or carcinoma are intracranial lesions and seldom
cause bony destruction. Middle ear carcinoma starts
from the TC and contains no papillary or cystic struc⁃
tures（suggestive of middle ear invasion by ELST when
present）but epithelial cells with filaments on electric
microscopy.
To summarize, clinical features in ELST include
SNHL, female gender preponderance, retropetrous le⁃
sion easily separated from the dura, destruction of mid⁃
dle and posterior portion of the petrous temporal bone
with irregular enhancement on imaging, rich blood sup⁃
ply, and papillary and/or cystic structures on histologi⁃
cal examination.
The preferred treatment is surgical resection. Preoper⁃
ative embolization helps reduce intraoperative bleeding,
surgical time and postoperative complications［6］. The
supplying artery is usually from the external carotid ar⁃
tery（posterior auricular, occipital, ascending pharyngeal
arteries, etc）or vertebral artery（usually anterior inferior
cerebellar artery）. A retroauricular approach is pre⁃
ferred because of the lesion’s retrolabyrinthine location.
A combined lateral ear-neck approach is helpful in a le⁃
sion with extensive involvement. Approach begins with a
mastoidectomy with exposure of the sigmoid and posteri⁃
or cranial fossa dura. Preservation of posterior wall of
the EAC is possible when it is free of lesion, but the wall
can be removed and the entire EAC obliterated if need⁃
ed. Subtotal temporal bone resection is sometimes neces⁃
sary. Efforts should be made to preserve the facial nerve
and fallopian canal, but lesion-laden facial nerve
should resected with the tumor with primary HFNA or
transplant with the great auricular nerve graft. Involved
dura should be resected with the tumor and the defect re⁃
paired with myofascia from the temporalis. Surgical de⁃
fect can be obliterated with muscle or fatty tissue graft
after ample irrigation. Regular irradiation or chemothera⁃
pies are not effective in ELST, but gamma-knife treat⁃
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ment may be helpful［10］.
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